Redwood City, CA, United States of America

Britton Kenneth Corkey

This inventor holds 31 USPTO granted patents and 4 published patent applications, plus 4 CIPO patents and 19 EPO patents. Top assignees: Gilead Sciences, Inc., Novartis Ag. Active years: 2013-2025.

USPTO Granted Patents = 31 (Patent Applications = 4)

% Patents Active = 100.0

CIPO Patents = 4 (Patent Applications = 6)

EPO Patents = 19 (Patent Applications = 22)

Average Co-Inventor Count = 7.2

ph-index = 10

Forward Citations = 270(Granted Patents)

Location History:

Redwood, CA (US) (2013)
San Francisco, CA (US) (2013 - 2016)
Redwood City, CA (US) (2013 - 2022)
Foster City, CA (US) (2023)

Company Filing History:

31 out of 946

Gilead Sciences, Inc.

where one patent can have more than one assignee

Years Active: 2013-2025

Loading Chart...

Areas of Expertise:

Antiviral Compounds

Pyrazolopiridinone Compounds

Heterocyclic Compounds

Apoptosis Signal-Regulating Kinase Inhibitors

Benzimidazole Derivatives

Bromodomain Inhibitors

Fused Heterocyclic Compounds

Ion Channel Modulators

Quinoline Derivatives

Imidazopyridine Compounds

Carboximidamide Compounds

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12338220 - Antiviral pyrazolopiridinone compounds (2025-06-24),

2. 11667613 - Antiviral pyrazolopyridinone compounds (2023-06-06),

3. 11229638 - Therapeutic heterocyclic compounds (2022-01-25),

4. 11186579 - Therapeutic heterocyclic compounds (2021-11-30),

5. RE48711 - Apoptosis signal-regulating kinase inhibitors (2021-08-30),

6. 11098027 - Therapeutic heterocyclic compounds (2021-08-24),

7. 11040033 - Therapeutic heterocyclic compounds (2021-06-22),

8. RE48150 - Apoptosis signal-regulating kinase inhibitors (2020-08-10),

9. 10017501 - Benzimidazole derivatives as bromodomain inhibitors (2018-07-10),

10. 9951065 - Benzimidazole and imadazopyridine carboximidamide compounds (2018-04-24),

11. 9695192 - Fused heterocyclic compounds as ion channel modulators (2017-07-04),

12. 9682998 - Fused heterocyclic compounds as ion channel modulators (2017-06-20),

13. 9676760 - Fused heterocyclic compounds as ion channel modulators (2017-06-13),

14. 9598435 - Fused heterocyclic compounds as ion channel modulators (2017-03-21),

15. 9586932 - Apoptosis signal-regulating kinase inhibitors (2017-03-07),

Title: The Inventor Britton Kenneth Corkey: Pioneering Innovations in Redwood City

Introduction: Britton Kenneth Corkey is a distinguished inventor based in Redwood City, California, known for his groundbreaking contributions to various technological fields.

Latest Patents: Britton Kenneth Corkey holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his versatility and ingenuity in the realm of innovation.

Career Highlights: With a career spanning over two decades, Britton Kenneth Corkey has worked with leading research institutions and companies to develop cutting-edge solutions that have had a significant impact on society.

Collaborations: Throughout his career, Britton Kenneth Corkey has collaborated with top engineers, scientists, and designers, fostering a culture of innovation and excellence in all his projects.

Conclusion: Britton Kenneth Corkey's passion for pushing the boundaries of technology and his relentless pursuit of innovation continue to inspire the next generation of inventors and entrepreneurs.